MCID: RTN021
MIFTS: 42

Retinal Vascular Occlusion malady

Categories: Eye diseases, Cardiovascular diseases

Aliases & Classifications for Retinal Vascular Occlusion

About this section

Aliases & Descriptions for Retinal Vascular Occlusion:

Name: Retinal Vascular Occlusion 10 47 12 65
Retinal Vascular Occlusion, Unspecified 10
Unspecified Retinal Vascular Occlusion 10
 
Retinal Vascular Occlusion Nos 10
Retinal Vasc. Occlusion 10

Classifications:



External Ids:

Disease Ontology10 DOID:1729
ICD1027 H34, H34.9
ICD9CM29 362.3, 362.30
NCIt42 C34980
UMLS65 C0035326

Summaries for Retinal Vascular Occlusion

About this section
MalaCards based summary: Retinal Vascular Occlusion, also known as retinal vascular occlusion, unspecified, is related to central retinal artery occlusion and central retinal vein occlusion. An important gene associated with Retinal Vascular Occlusion is F5 (Coagulation Factor V), and among its related pathways are Glypican 1 network and Immune response_Oncostatin M signaling via JAK-Stat in human cells. Affiliated tissues include eye, endothelial and bone, and related mouse phenotypes are liver/biliary system and vision/eye.

Related Diseases for Retinal Vascular Occlusion

About this section

Diseases related to Retinal Vascular Occlusion via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 216)
idRelated DiseaseScoreTop Affiliating Genes
1central retinal artery occlusion10.8
2central retinal vein occlusion10.8
3transient retinal arterial occlusion10.7
4mayer-rokitansky-kuster-hauser syndrome10.5APOH, F5
5amelia cleft lip palate hydrocephalus iris coloboma10.5F5, MTHFR
6muller barth menger syndrome10.5F5, MTHFR
7retinal dystrophy, iris coloboma, and comedogenic acne syndrome10.5F5, SELP
8azygos continuation of the inferior vena cava10.4F5, MTHFR
9cavernous sinus thrombosis10.4F5, MTHFR
10breast abscess10.4F5, MTHFR
11lateral sinus thrombosis10.4F5, SERPINC1
12hemiplegia alterans10.4MTHFR, VEGFA
13sertoli cell tumor10.4F5, SERPINC1
14renal fibrosis10.4MTHFR, SELP
15internuclear ophthalmoplegia10.4F2, F5
16acquired thrombocytopenia10.4F2, SELP
17hemoglobinopathy10.4F5, MTHFR
18dysthymic disorder10.4F2, F5
19segawa syndrome, recessive10.4F2, SELP
20pulmonary fibrosis, familial10.4F2, MTHFR
21causalgia10.4APOH, MTHFR
22facioscapulohumeral muscular dystrophy 110.3F2, F5
23myopia10.3CRYAA, VEGFA
24fowler's syndrome10.3F2, SERPINC1
25angioedema, hereditary, type iii10.3F5, SERPINC1
26crohn's disease10.3F5, IL6
27silo filler's disease10.3F2, SERPINC1
28acanthosis nigricans10.3IL6, SELP
29intracranial vasospasm10.3F5, PLG
30moderately severe hemophilia a10.3F2, F5
31inferior myocardial infarction10.3F2, SERPINC1
32thyrocalcitonin secretion disease10.3CRYAA, VEGFA
33meningoencephalocele10.3F5, SERPINC1
34psychologic vaginismus10.3F5, MTHFR, SELP
35catatrichy10.3APOH, F5, MTHFR
36pregnancy loss, recurrent 110.3APOH, F5, MTHFR
37chronic venous leg ulcers10.3PLG, VEGFA
38stickler sydrome, type i, nonsyndromic ocular10.3F5, SELP, SERPINC1
39meconium aspiration syndrome10.3F5, IL6
40primary gastrointestinal melanoma10.3IL6, VEGFA
41irak4 deficiency10.3F2, F5
42residual stage angle-closure glaucoma10.3IL6, VEGFA
43panic disorder10.3APOH, F5, SERPINC1
44kidney sarcoma10.3F2, SERPINC1
45nerve plexus neoplasm10.3CRYAA, VEGFA
46paranoid schizophrenia10.3IL6, VEGFA
47tall stature-scoliosis-macrodactyly of the great toes syndrome10.3APOH, F2, F5
48hypermobility of coccyx10.2F2, F5, SELP
49partial motor epilepsy10.2APOH, SELP, SERPINC1
50diffuse meningeal melanocytosis10.2F2, SERPINC1

Graphical network of the top 20 diseases related to Retinal Vascular Occlusion:



Diseases related to retinal vascular occlusion

Symptoms for Retinal Vascular Occlusion

About this section

Drugs & Therapeutics for Retinal Vascular Occlusion

About this section

Drugs for Retinal Vascular Occlusion (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 142)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Bevacizumabapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 11875216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
2
Dexamethasoneapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 1190950-02-25743
Synonyms:
(3H)-Dexamethasone
.delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol
.gamma.corten
1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone
1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone
1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone
1-Dehydro-16α-methyl-9α-fluorohydrocortisone
137098-19-2
16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol
16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone
16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone
16-alpha-Methyl-9-alpha-fluoroprednisolone
16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol
16.alpha.-Methyl-9.alpha.-fluoroprednisolone
16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol
16alpha -Methyl-9alpha -fluoroprednisolone
16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol
16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone
16alpha-Methyl-9alpha-fluoroprednisolone
16α-Methyl-9α-fluoro-1-dehydrocortisol
23495-06-9
31375_FLUKA
46165_FLUKA
46165_RIEDEL
50-02-2
8054-59-9
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione
9-Fluoro-16-methylprednisolone
9-alpha-Fluoro-16-alpha-methylprednisolone
9.alpha.-Fluoro-16.alpha.-methylprednisolone
906422-84-2
9A-FLUORO-16BETA-METHYLPREDNISOLONE
9alpha -Fluoro-16alpha -methylprednisolone
9alpha-Fluoro-16alpha-methylprednisolone
9alpha-fluoro-16alpha-methyl-Prednisolone
9α-Fluoro-16α-methylprednisolone
AC-11056
AC1L1L1H
AC1Q29DM
AI3-50934
Adexone
Aeroseb-D
Aeroseb-Dex
Aeroseb-dex
Ak Dex Oph Otic Soln 0.1%
Alcon Brand of Dexamethasone
Anaflogistico
Aphtasolon
Aphthasolone
Apo-dexamethasone
Auxiron
Azimycin (veterinary)
Azium
Azium (Veterinary)
Azium (veterinary)
BIDD:ER0494
BIDD:PXR0060
BRD-K38775274-001-02-3
BRD-K38775274-001-06-4
BSPBio_000995
Baycadron
Bisu DS
Bisu Ds
C15643
C22H29FO5
CCRIS 7067
CHEBI:41879
CHEMBL384467
CID5743
CPD-10549
CPD001227192
Calonat
Corson
Corsone
Cortisumman
D00292
D003907
D1756_SIGMA
D4902_SIGMA
D6645_SIGMA
D8893_SIGMA
D9184_SIGMA
DB01234
DEX
DEXA
DEXONE 0.5
DEXONE 0.75
DEXONE 1.5
DEXONE 4
DXM
DXMS
Decacort
Decacortin
Decaderm
Decadron
Decadron (TN)
Decadron Tablets, Elixir
Decadron, Dexamethasone
Decadron-LA
Decadron-La
Decagel
Decaject
Decaject L.A.
Decaject-L.A.
Decalix
Decameth
Decasone
Decaspray
Dectancyl
Dekacort
Delta1-9alpha-Fluoro-16alpha-methylcortisol
Deltafluorene
Dergramin
Deronil
Desadrene
Desametasone
Desametasone [DCIT]
Desametasone [Dcit]
Desamethasone
Desameton
Deseronil
Dex-Ide
Dex-ide
Dexa
Dexa Mamallet
Dexa mamallet
Dexa-Cortidelt
Dexa-Cortisyl
Dexa-Mamallet
Dexa-Scheroson
Dexa-Sine
Dexa-cortidelt
Dexa-cortisyl
Dexa-scheroson
Dexa-sine
Dexacen-4
Dexacidin
Dexacort
Dexacortal
Dexacortin
Dexadeltone
Dexafarma
Dexair
Dexalona
Dexaltin
Dexametasona
Dexametasona [INN-Spanish]
Dexametasone
Dexameth
Dexamethansone
 
Dexamethasone
Dexamethasone (JP15/USP/INN)
Dexamethasone Acetate
Dexamethasone Alcohol
Dexamethasone Base
Dexamethasone Intensol
Dexamethasone Sodium Phosphate
Dexamethasone [INN:BAN:JAN]
Dexamethasone acetate
Dexamethasone alcohol
Dexamethasone base
Dexamethasone intensol
Dexamethasone sodium phosphate
Dexamethasone-omega
Dexamethasonum
Dexamethasonum [INN-Latin]
Dexamethazone
Dexamethsone
Dexamonozon
Dexapolcort
Dexapos
Dexaprol
Dexason
Dexasone
Dexasone 0.5mg
Dexasone 0.75mg
Dexasone 4mg
Dexasporin
Dexinolon
Dexinoral
Dexone
Dexone 0.5
Dexone 0.75
Dexone 1.5
Dexone 4
Dexonium
Dexpak
Dextelan
Dezone
Dinormon
Dxms
ECR Brand of Dexamethasone
EINECS 200-003-9
FT-0080377
Fluormethylprednisolone
Fluormone
Fluorocort
Fortecortin
Foy Brand of Dexamethasone
Gammacorten
HL-dex
HMS1792A17
HMS1990A17
HMS2089N13
HSDB 3053
Hexadecadrol
Hexadrol
Hexadrol Elixir
Hexadrol Tablets
Hexadrol elixir
Hl-Dex
Hl-dex
I06-1196
ICN Brand of Dexamethasone
IontoDex
Isopto-Dex
Isopto-dex
LS-7300
Lokalison F
Lokalison f
Loverine
Luxazone
MK 125
MLS001055412
MLS001332507
MLS001332508
Maxidex
Maxidex Ont 0.1%
Maxidex Sus 0.1%
Maxitrol
Mediamethasone
Merck Brand of Dexamethasone
Merz Brand 1 of Dexamethasone
Merz Brand 2 of Dexamethasone
Methylfluorprednisolone
Mexidex
Millicorten
MolMap_000018
MolPort-003-846-433
Mymethasone
NCGC00091019-01
NCGC00091019-02
NCGC00091019-03
NCGC00091019-04
NCGC00091019-05
NCI60_003067
NSC 34521
NSC34521
Naquasone (veterinary)
Neomycin and polymyxin b sulfates and dexamethasone
Neomycin and polymyxin b sulphates and dexamethasone
OTO-104
Ocu-Trol
Ocu-trol
Oradexon
Ozurdex
PHL-dexamethasone
PMS-dexamethasone
Pet Derm III
Pet Derm Iii
Pet derm III
Pet-Derm Iii
Pms Dexamethasone Elixir 0.5mg/5ml
Policort
Posurdex
Prednisolon F
Prednisolon f
Prednisolone F
Prednisolone f
Prodex
S1322_Selleck
SAM002548948
SGCUT00126
SK-Dexamethasone
SK-dexamethasone
SMP1_000092
SMR000857119
SMR001227192
ST50307091
Sandoz dexamethasone
Sk-Dexamethasone
Spectrum5_002019
Spoloven
Sunia Sol D
Sunia sol D
Superprednol
TL8003317
Tobradex
Tobramycin and dexamethasone
Tresaderm (veterinary)
Turbinaire
UNII-7S5I7G3JQL
Visumetazone
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1
ZINC03875332
alpha -Fluoro-16-alpha -methylcortisol
delta(Sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol
delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol
delta1-9alpha-Fluoro-16alpha-methylcortisol
dexamethasone
nchembio809-comp2
to_000038
3
AspirinapprovedPhase 4, Phase 3102950-78-22244
Synonyms:
11126-35-5
11126-37-7
1oxr
2-(ACETYLOXY)benzoic acid
2-(Acetyloxy)benzoate
2-(Acetyloxy)benzoic acid
2-Acetoxybenzenecarboxylic acid
2-Acetoxybenzoate
2-Acetoxybenzoic acid
2-Carboxyphenyl acetate
2349-94-2
26914-13-6
50-78-2
7 Select Adult Chewable Aspirin
7 Select Aspirin
8-hour Bayer
98201-60-6
A 5376
A.S.A
A.S.A.
A.S.A. Empirin
A.S.A. empirin
A2093_SIGMA
A3160_SIGMA
A5376_SIGMA
A6810_SIGMA
AB1003266
AC 5230
AC1L1D8U
AC1Q1LA0
ACETYLSALICYLIC ACID
AI3-02956
AIN
AKOS000118884
ASA
Acenterine
Acesal
Acetal
Acetard
Aceticyl
Acetilsalicilico
Acetilum acidulatum
Acetisal
Acetol
Acetonyl
Acetophen
Acetosal
Acetosalic acid
Acetosalin
Acetoxybenzoic acid
Acetylin
Acetylsal
Acetylsalicylate
Acetylsalicylic acid
Acetylsalicylsaeure
Acetylsalicylsaure
Acetylsalycilic acid
Acetyonyl
Acetysal
Acetysalicylic acid
Acide 2-(acetyloxy)benzoique
Acide acetylsalicylique
Acide acétylsalicylique
Acido O-acetil-benzoico
Acido acetilsalicilico
Acidum acetylsalicylicum
Acimetten
Acisal
Acylpyrin
Adiro
Adult Chewable Low Dose Aspirin
Adult Low Dose Aspirin
Adult Low Dose Aspirin Enteric Safety Coated
Adult Low Dose Enteric Coated Aspirin
Adult Low Strength Aspirin
Aloxiprimum
Asacard
Asagran
Asaphen
Asatard
Ascoden-30
Ascriptin Maximum Strength Buffered Aspirin
Ascriptin Regular Strength Buffered Aspirin
Aspalon
Aspec
Aspergum
Aspi-cor
Aspir Low
Aspir-Mox
Aspirdrops
Aspirin
Aspirin (JP15/USP)
Aspirin 81 Mg
Aspirin 81 Mg Low Dose
Aspirin Adult Low Dose
Aspirin Adult Low Strength
Aspirin Adult Low Strength Aspirin
Aspirin Adult low strength
Aspirin Chewable Low Dose
Aspirin Delayed Release
Aspirin EC
Aspirin EXTRA STRENGTH
Aspirin Ec
Aspirin Enteric
Aspirin Enteric Coated
Aspirin Enteric Coated Low Dose
Aspirin Enteric Safety Coated
Aspirin Enteric Safety-Coated
Aspirin Low Dose
Aspirin Low Dose Chewable
Aspirin Low Dose Enteric Coated
Aspirin Low Dose Safety Coated
Aspirin Low Strength
Aspirin Nsaid
Aspirin Regular Strength
Aspirin Regular Strength regular strength
Aspirin Regular strength
Aspirin Safety Coated
Aspirin Safety Coated Adult Low Dose
Aspirin Safety coated
Aspirin Thin coated
Aspirin [BAN:JAN]
Aspirin adult low dose
Aspirin adult low strength
Aspirin enteric safety coated
Aspirin low dose
Aspirin low dose chewable
Aspirin low dose enteric coated
Aspirin regular strength
Aspirina 03
Aspirine
Aspiring
Asprin
Aspro
Aspro Clear
Asteric
Azetylsalizylsaeure
Azetylsalizylsäure
BIDD:GT0118
BRN 0779271
Bay-e-4465
Bayer
Bayer Advanced Aspirin Extra Strength
Bayer Advanced Aspirin Regular Strength
Bayer Aspirin 8 Hour
Bayer Aspirin Regimen Chewable Low Dose Aspirin Orange
Bayer Aspirin Regimen Regular Strength
Bayer Buffered
Bayer Chewable - Aspirin Regimen Low Dose Aspirin Cherry Flavored
Bayer Extra Strength Aspirin For Migraine Pain
Bayer Fast Release
Bayer Genuine Aspirin
Bayer Low Dose
Bayer Plus
Bayer Plus Extra Strength
Bayer Womens
Benaspir
Bi-prin
Bialpirina
Bialpirinia
Buffered Aspirin
Bufferin
Bufferin LOW DOSE BUFFERED ASPIRIN
C01405
CCRIS 3243
CHEBI:15365
CHEMBL25
CID2244
Caprin
Cardioaspirin
Cardioaspirina
Care One Aspirin
Cemirit
Chewable Adult Low Dose Aspirin
Chewable Aspirin
Chewable Low Dose Aspirin
Claradin
Clariprin
Colfarit
Contrheuma retard
Coricidin
Critical Care Aspirin To Go
Crystar
D00109
D001241
DB00945
Decaten
Delgesic
Dg Health Aspirin
Direct Safety Aspirin
Dispril
DivK1c_000555
Dolean pH 8
Duramax
ECM
EINECS 200-064-1
EU-0100038
Easprin
Easprin (TN)
Ec-81aspirin Enteric Coated
Ecolen
Ecotrin
Ecotrin Regular Strength
Empirin
Empirin with Codeine
Endosprin
Endydol
Enteric Aspirin
Enteric Coated Aspirin
Enteric Coated Aspirin Regular Strength
Enteric Coated Aspirin Regular strength
Enteric Coated Aspirin regular strength
Enteric Coated Asprin 81 Mg
Enteric Coated Low Dose Aspirin
 
Enteric Safety Coated Aspirin
Entericin
Enterophen
Enterosarein
Enterosarine
Entrophen
Equaline Aspirin
Equaline Aspirin adult low dose
Equate Aspirin
Equate Aspirin chewable
Extren
Fasprin
Flanax Aspirin Pain Reliever
Formucare Aspirin
Genuine Aspirin
Globentyl
Globoid
Good Neighbor Pharmacy Aspirin
Good Neighbor Pharmacy Aspirin Enteric Safety Coated
Good Neighbor Pharmacy Aspirin orange flavor chewable
Good Sense Aspirin
Good Sense Aspirin Enteric Safety Coated
HMS1920E13
HMS2090G03
HMS2091K13
HMS501L17
HSDB 652
Handy Solutions Genuine Aspirin Bayer
Health Mart Aspirin
Health Mart Regular Strength Enteric Coated Aspirin
Health Sense Adult Chewable Low Strength Aspirin
Health Sense Aspirin 81
Health Sense Ecpirin
Healthy Accents Aspirin
Helicon
Henry Schein Aspirin
I14-7505
IDI1_000555
Idragin
Istopirin
KBio1_000555
KBio2_001725
KBio2_002271
KBio2_004293
KBio2_004839
KBio2_006861
KBio2_007407
KBio3_002149
KBio3_002751
KBioGR_000398
KBioGR_002271
KBioSS_001725
KBioSS_002272
Kapsazal
Kroger Value Aspirin
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
LS-143
Leader Aspirin
Leader Cardinal Health Aspirin
Leader Low Dose Aspirin
Levius
Lopac-A-5376
Lopac0_000038
Low Dose Adult Aspirin
Low Dose Aspirin
Low Dose Aspirin 81 Mg Safety Coated
Low Dose Aspirin Enteric Safety Coated
Low Dose Asprin
Low Dose Chewable Aspirin
Low Dose Miniprin Enteric Safety Coated
Low Dose Pain Relief Aspirin
Low Strength Chewable Aspirin
Low-dose Aspirin
MLS001055329
MLS001066332
MLS001336045
MLS001336046
Magnecyl
Measurin
Medi First Plus Aspirin
Medi-first Aspirin
Medique Aspirin
Medisyl
Micristin
Micro-coated Aspirin
Miniprin
MolPort-000-871-622
NCGC00015067-01
NCGC00015067-04
NCGC00015067-09
NCGC00090977-01
NCGC00090977-02
NCGC00090977-03
NCGC00090977-04
NCGC00090977-05
NCGC00090977-06
NCGC00090977-07
NCI60_002222
NINDS_000555
NSC 27223
NSC27223
NSC406186
Neuronika
North Aspirin
Novasen
Novid
Nu-seals
Nu-seals aspirin
O-(Acetyloxy)benzoate
O-(Acetyloxy)benzoic acid
O-Acetoxybenzoate
O-Acetoxybenzoic acid
O-Acetylsalicylic acid
O-Carboxyphenyl acetate
O-accetylsalicylic acid
O-acetylsalicylic acid
PL-2200
Pain Relief Aspirin
Pain Relief Aspirin Low Dose
Persistin
Pharbest Aspirin 325mg
Pharbest Regular Strength Aspirin
Pharmacin
Pirseal
Plus Pharma NSAID 325 mg
Plus Pharma Nsaid Aspirin
Polopirin
Polopiryna
Premaspin
R16CO5Y76E [UNII]
Rapid Comfort Aspirin
Regular Strength Aspirin
Regular Strength Aspirin Ec
Regular Strength Buffered Aspirin
Regular Strength Enteric Aspirin
Regular Strength Enteric Coated Aspirin
Regular Strength Pain Relief
Regular Strength Tri-buffered Aspirin
Rexall Aspirin
Rheumin tabletten
Rheumintabletten
Rhodine
Rhonal
Ronal
Rugby Aspirin
Rx Act Aspirin
S-211
SMR000059138
SP 189
SPBio_001838
SPECTRUM1500130
ST075414
Safety Coated Aspirin
Safety Coated Enteric Aspirin
Salacetin
Salcetogen
Saletin
Salicylic acid acetate
Salicylic acid, acetate
Salospir
Smart Health Aspirin regular strength
Smart Sense Aspirin
Solfrin
Solprin
Solprin acid
Solpyron
Solupsan
Solves - Aspirin Cherry
Spectrum2_001899
Spectrum3_001295
Spectrum4_000099
Spectrum5_000740
Spectrum_001245
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
St. Joseph Chewable Aspirin
St. Joseph Safety Coated Aspirin
Sunmark Aspirin
Sunmark Aspirin Regular Strength
Sunmark Aspirin adult low strength
Sunmark Aspirin low dose
Supac
Tasprin
Temperal
Toldex
Topcare Aspirin
Tri-buffered Aspirin
Triaminicin
Triple-sal
UNII R16CO5Y76E
UNII-R16CO5Y76E
UNII=R16CO5Y76E
UNM-0000306102
Uncoated Aspirin
Value Pharma Aspirin Pain Reliever
Value Pharmapain Reliever Extra Strength
Vanquish
WLN: QVR BOV1
XAXA
Xaxa
Yasta
ZORprin
Zee Aspirin
aspirin
cMAP_000006
component of Midol
component of Synirin
nchem.859-comp6
o-Acetoxybenzoic acid
o-Carboxyphenyl acetate
o-acetoxybenzoic acid
o-carboxyphenyl acetate
ácido acetilsalicílico
4
TriamcinoloneapprovedPhase 4, Phase 3, Phase 2, Phase 1448124-94-731307
Synonyms:
(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
11-beta,16-alpha,17-alpha,21-Tetrahydroxy-9-alpha-fluoro-1,4-pregnadiene-3,20-dione
11.Beta.,16.alpha.,17.alpha., 21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11.beta.,16.alpha.,17.alpha.,21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11beta,16alpha,17alpha,21-Tetrahydroxy-9alpha-fluoro-1,4-pregnadiene-3,20-dione
124-94-7
4-08-00-03629 (Beilstein Handbook Reference)
83474-03-7
9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-16-alpha-hydroxyprednisolone
9.Alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahy
9.Alpha.-Fluoro-11.beta.,16.alpha.,17.alpha., 21-tetrahydroxypregna-1,4-diene-3,20-d
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-16.alpha.-hydroxyprednisolone
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-Fluoro-11beta,16alpha,17alpha,21-tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-Fluoro-16alpha-hydroxyprednisolone
9α-fluoro-16α-hydroxyprednisolone
AC-2072
AC1L1LDH
AC1Q5HJC
Adcortyl
Allernaze
Aristocort
Aristocort A
Aristocort Tablets
Aristogel
Aristospan
Azmacort
BPBio1_000154
BRD-K77554836-001-03-3
BRN 2341955
BSPBio_000140
Bio-0662
C21H27FO6
CHEMBL1451
CID31307
CL 19823
Celeste
Cinolone
Cinolone-T
D00385
D014221
DB00620
Delphicort
EINECS 204-718-7
EU-0101179
Fluoxiprednisolone
Fluoxyprednisolone
Flutex
Fougera
HMS1568G22
HMS2090D12
HSDB 3194
Kenacort
Kenacort (TN)
Kenacort-A
Kenacort-AG
Kenacort-Ag
Kenalog
Kenalog in Orabase
Kenalog-10
Kenalog-40
Kenalog-H
LS-698
Ledercort
Lopac0_001179
MLS000028542
MLS001066543
 
MLS002695935
MolPort-002-528-981
Mycolog
NCGC00021580-03
NCGC00021580-04
NCGC00021580-05
NCGC00021580-06
NCGC00021580-07
NCI60_000750
NSC 13397
NSC13397
Nasacort
Nasacort Aq
Nasacort Hfa
Omcilon
Omicilon
Oracort
Oralone
Orion
Polcortolon
Pregna-1,4-diene-3,20-dio
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha)
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy- (8CI)
Prestwick0_000120
Prestwick1_000120
Prestwick2_000120
Prestwick3_000120
Prestwick_438
Rodinolone
S1933_Selleck
SK-Triamcinolone
SMP1_000300
SMR000058333
SPBio_002079
Sk-Triamcinolone
T6376_SIGMA
TRIAMCINOLONE (SEE ALSO TRIAMCINOLONE ACETONIDE (76-25-5) AND TRIAMCINOLONE DIACETATE (67-78-7))
Tiamcinolonum
Tiamcinolonum [INN-Latin]
Tri-Nasal
Triacet
Triacort
Triam-Tablinen
Triamcet
Triamcinalone
Triamcinlon
Triamcinolon
Triamcinolona
Triamcinolona [INN-Spanish]
Triamcinolone (JP15/USP/INN)
Triamcinolone Acetonide
Triamcinolone [USAN:INN:BAN:JAN]
Triamcinolone acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Triamcinolonum
Triamcinolonum [INN]
Trianex
Triatex
Tricortale
Triderm
Triesence
Trilone
Tristoject
Trymex
UNII-1ZK20VI6TY
Vetalog
Volon
Volon A
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ GQ
ZINC03882036
droxypregna-1,4-diene-3,20-dione
ione
nchembio.2007.53-comp7
triamcinolone
5
RanibizumabapprovedPhase 4, Phase 3, Phase 2, Phase 1460347396-82-1459903
Synonyms:
347396-82-1
D05697
Lucentis
Lucentis (TN)
 
Ranibizumab
Ranibizumab (USAN/INN)
Ranibizumab (genetical recombination)
Ranibizumab (genetical recombination) (JAN)
ranibizumab
rhuFab V2
6
DipyridamoleapprovedPhase 47658-32-23108
Synonyms:
2,6-Bis(diethanolamine)-4,8-dipiperidinopyrimido[5,4-d]pyrimidine
2,6-Bis(diethanolamino)-4,8-dipiperidinopyrimido(5,4-d)pyrimidine
2,6-Bis(diethanolamino)-4,8-dipiperidinopyrimido[5,4-d]pyrimidine
4-26-00-03840 (Beilstein Handbook Reference)
58-32-2
AB00051974
AC-18100
AC1L1F6T
AC1Q7CXU
AC1Q7CXW
AC1Q7CXX
AKOS000509426
Agilease
Anginal
Antistenocardin
Apo-Dipyridamole
Apo-Dipyridamole Fc
Apo-Dipyridamole Sc
Apotex Brand of Dipyridamole
Apricor
Ashbourne Brand of Dipyridamole
BAS 00818792
BIM-0050449.0001
BPBio1_000270
BRD-K86301799-001-04-1
BRN 0068373
BSPBio_000244
BSPBio_001554
BSPBio_001924
Belmac Brand of Dipyridamole
Berlin Chemie Brand of Dipyridamole
Berlin-Chemie Brand of Dipyridamole
Bio-0173
Boehringer Ingelheim Brand of Dipyridamole
C24H40N8O4
CAS-58-32-2
CHEBI:4653
CHEMBL932
CID3108
CPD000058382
Cardioflux
Cardoxil
Cardoxin
Cerebrovase
Chilcolan
Cleridium
Cleridium 150
Coribon
Coridil
Coronarine
Corosan
Coroxin
Curantil
Curantyl
D 9766
D00302
D004176
D2274
D9766_SIGMA
DB00975
Dipiridamol
Dipiridamol [INN-Spanish]
Dipyramidole
Dipyridamine
Dipyridamol
Dipyridamole
Dipyridamole (JP15/USP/INN)
Dipyridamole [USAN:INN:BAN:JAN]
Dipyridamolum
Dipyridamolum [INN-Latin]
Dipyridan
Dipyudamine
DivK1c_000696
Dypyridamol
EINECS 200-374-7
EU-0100464
Gulliostin
HMS1568M06
HMS1791N16
HMS1920I10
HMS1989N16
HMS2089N15
HMS2091O18
 
HMS502C18
IDI1_000696
IPRAD Brand of Dipyridamole
Iv Persantine
Justpertin
KBio1_000696
KBio2_001484
KBio2_004052
KBio2_006620
KBio3_001144
KBioGR_001123
KBioSS_001484
Kurantil
LS-66732
Lopac-D-9766
Lopac0_000464
MLS000028420
MLS001076306
MLS001333724
Miosen
MolPort-001-792-504
NCGC00015385-01
NCGC00015385-02
NCGC00015385-03
NCGC00015385-07
NCGC00015385-15
NCGC00023914-02
NCGC00023914-04
NCGC00023914-05
NCGC00023914-06
NCGC00023914-07
NCGC00023914-08
NCGC00023914-09
NCGC00023914-10
NCGC00023914-11
NCI60_005689
NINDS_000696
NSC 515776
NSC-515776
NSC515776
Natyl
Novo-Dipiradol
Novopharm Brand of Dipyridamole
Peridamol
Permiltin
Permole, Persantine, Dipyridan, Dipyridamole
Persantin
Persantine
Persantine (TN)
Piroan
Prandiol
Prandiol 75
Prestwick0_000142
Prestwick1_000142
Prestwick2_000142
Prestwick3_000142
Prestwick_145
Protangix
RA 8
RA-8
S1867_Selleck
S1895_Selleck
SAM002264609
SMP2_000208
SMR000058382
SPBio_001003
SPBio_002183
SPECTRUM1500259
Spectrum2_000972
Spectrum3_000402
Spectrum4_000522
Spectrum5_000839
Spectrum_001004
Stenocardil
Stenocardiol
Stimolcardio
Tocris-0691
UNII-64ALC7F90C
UPCMLD-DP072
UPCMLD-DP072:001
Usaf Ge-12
WLN: T66 BN DN GN INJ CCN HCN E- AT6NTJ B2Q F2Q& J- AT6NTJ B2Q F2Q
ZINC00643046
dipyridamole
7
Verteporfinapproved, investigationalPhase 483129497-78-55362420
Synonyms:
Verteporfin
Verteporfina
 
Verteporfinum
Vertéporfine
Visudyne
8Endothelial Growth FactorsPhase 4, Phase 3, Phase 1, Phase 2328
9Cyclooxygenase InhibitorsPhase 4, Phase 32225
10Fibrinolytic AgentsPhase 4, Phase 3, Phase 11567
11Antirheumatic AgentsPhase 4, Phase 3, Phase 1, Phase 28496
12Anti-Inflammatory Agents, Non-SteroidalPhase 4, Phase 33549
13AnalgesicsPhase 4, Phase 39358
14Analgesics, Non-NarcoticPhase 4, Phase 35184
15Platelet Aggregation InhibitorsPhase 4, Phase 31935
16AntipyreticsPhase 4, Phase 31140
17MitogensPhase 4, Phase 3, Phase 1, Phase 21386
18Dermatologic AgentsPhase 4, Phase 1, Phase 24555
19AnestheticsPhase 4, Phase 37385
20Angiogenesis InhibitorsPhase 4, Phase 3, Phase 2, Phase 13688
21Triamcinolone hexacetonidePhase 4, Phase 3, Phase 2, Phase 1448
22Triamcinolone diacetatePhase 4, Phase 3, Phase 2, Phase 1448
23Angiogenesis Modulating AgentsPhase 4, Phase 3, Phase 2, Phase 13611
24triamcinolone acetonidePhase 4, Phase 3, Phase 2, Phase 1448
25MitomycinsPhase 4219
26Immunosuppressive AgentsPhase 4, Phase 3, Phase 2, Phase 110422
27Dexamethasone 21-phosphatePhase 4, Phase 3, Phase 2, Phase 11909
28Dexamethasone acetatePhase 4, Phase 3, Phase 2, Phase 119091177-87-3
29Gastrointestinal AgentsPhase 4, Phase 3, Phase 2, Phase 16401
30Immunologic FactorsPhase 4, Phase 3, Phase 2, Phase 118483
31BB 1101Phase 4, Phase 3, Phase 2, Phase 11909
32Anti-Inflammatory AgentsPhase 4, Phase 3, Phase 2, Phase 1, Phase 08478
33Antineoplastic Agents, HormonalPhase 4, Phase 3, Phase 2, Phase 14256
34Pharmaceutical SolutionsPhase 4, Phase 3, Phase 1, Phase 27004
35glucocorticoidsPhase 4, Phase 3, Phase 2, Phase 1, Phase 03896
36HIV Protease InhibitorsPhase 4, Phase 3, Phase 2, Phase 14558
37Protease InhibitorsPhase 4, Phase 3, Phase 2, Phase 14558
38
LactitolPhase 4320585-86-43871
Synonyms:
4-O-b-D-Galactopyranosyl-D-glucitol, 9CI
E966
Emportal
 
Floralac
Importal
Oponaf
Portolac
39Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 2, Phase 1, Phase 09988
40Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 2, Phase 118510
41AntiemeticsPhase 4, Phase 3, Phase 2, Phase 13213
42HormonesPhase 4, Phase 3, Phase 2, Phase 1, Phase 011748
43Hormone AntagonistsPhase 4, Phase 3, Phase 2, Phase 1, Phase 010002
44Hydroxymethylglutaryl-CoA Reductase InhibitorsPhase 4, Phase 31804
45Rosuvastatin CalciumPhase 4428147098-20-2
46Hypolipidemic AgentsPhase 4, Phase 3, Phase 22228
47Calcium, DietaryPhase 4, Phase 34678
48AntimetabolitesPhase 4, Phase 3, Phase 29454
49Photosensitizing AgentsPhase 4374
50Anticholesteremic AgentsPhase 4, Phase 31732

Interventional clinical trials:

(show top 50)    (show all 221)
idNameStatusNCT IDPhase
1Ranibizumab in Patients With Branch Retinal Vein OcclusionCompletedNCT01027481Phase 4
2Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein OcclusionCompletedNCT00406107Phase 4
3Morphological and Functional Retinal Changes Following Retinal PhotocoagulationCompletedNCT00682240Phase 4
4Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein OcclusionCompletedNCT01710839Phase 4
5Single Site, Masked, Randomized, Controlled Study to Assess Efficacy of Osurdex as Adjunct to Avastin Compared With Avastin Alone in the Treatment of Patients With Macular Edema Due to Central or Branch Retinal Vein OcclusionCompletedNCT01085734Phase 4
6Hemodilution Versus Ranibizumab in Early-onset Central Retinal Vein OcclusionCompletedNCT01448018Phase 4
7Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein OcclusionCompletedNCT01427751Phase 4
8A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein OcclusionCompletedNCT01903720Phase 4
9Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVOCompletedNCT01580020Phase 4
10A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein OcclusionCompletedNCT01277302Phase 4
11Dexamethasone-implant for the Treatment of RVOCompletedNCT01767545Phase 4
12Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular GlaucomaCompletedNCT01922154Phase 4
13ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia TrialCompletedNCT00161070Phase 4
14Intravitreal Macugen for Ischaemic Diabetic Macular OedemaCompletedNCT01175070Phase 4
15Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVORecruitingNCT02503540Phase 4
16Comparison of Retinal Oxygenation and Retinal Vessel Diameters in Healthy Subjects and Patients With Diabetic Retinopathy or Retinal Vein Occlusion Between DVA and OxymapRecruitingNCT02521116Phase 4
17Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein OcclusionRecruitingNCT01827722Phase 4
18Retinal Sensitivity in BRVO After Anti-VEGF TherapyRecruitingNCT02527733Phase 4
19Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein OcclusionRecruitingNCT02478515Phase 4
20Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVORecruitingNCT00566761Phase 4
21Comparing Injection Frequency Between Aflibercept and Ranibizumab in Patients With CRVO With a Treat& Extend RegimenRecruitingNCT02274259Phase 4
22Continuation of Previous Study to Gather More Data on Effect of Macugen on the Corneal EndotheliumRecruitingNCT01573572Phase 4
23Safety and Efficacy of Switching From Aflibercept to Ranibizumab in Patients With nAMDRecruitingNCT02161575Phase 4
24Cohort Study of the Clinical Course of Macular Diseases in KagawaRecruitingNCT02321267Phase 4
25The Prediction of Extent and Risk Profile of Coronary Atherosclerosis and Their Changes During Lipid-lowering Therapy Based on Non-invasive TechniquesRecruitingNCT01773512Phase 4
26Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF TherapyActive, not recruitingNCT01857544Phase 4
27NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein OcclusionsActive, not recruitingNCT01870427Phase 4
28Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair VisionActive, not recruitingNCT01795209Phase 4
29Evaluation of the "Treat-and-extend" Scheme in Patients With Retinal Vein Occlusion (RVO) With and Without LASER Treatment of Ischaemic Retinal AreasNot yet recruitingNCT02522897Phase 4
30Strategies for Management of Corneal NeovascularisationNot yet recruitingNCT02594423Phase 4
31Study to Evaluate Efficacy of Aflibercept in Neovascular Age-related Macular Degeneration Patients Non Responders to Anti-Vascular Endothelial Growth FactorNot yet recruitingNCT01896284Phase 4
32Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema.Not yet recruitingNCT02140411Phase 4
33TF (SENSIMED Triggerfish) in Intraocular Anti-VEGF (Vascular Endothelial Growth Factor) InjectionTerminatedNCT01983579Phase 4
34Ranibizumab and the Risk of Arterial Thromboembolic EventsTerminatedNCT01319188Phase 4
35Long-term Treatment Effect of Intravitreal Ant-VEGF in Branch Retinal Vein OcclusionCompletedNCT02033031Phase 3
36Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)CompletedNCT00943072Phase 3
37Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)CompletedNCT01012973Phase 3
38Steroid Injections vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel BlockageCompletedNCT00106132Phase 3
39Intravitreal Bevacizumab and Triamcinolone Associated to Laser Photocoagulation for Diabetic Macular Edema(IBeTA)CompletedNCT00997191Phase 3
40Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein OcclusionCompletedNCT00970957Phase 3
41The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) StudyCompletedNCT00105027Phase 3
42Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein OcclusionCompletedNCT01377597Phase 3
43Extended Follow-up of Patients With Macular Edema Due to Retinal Vein OcclusionCompletedNCT01198327Phase 3
44Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)CompletedNCT01396057Phase 3
45Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)CompletedNCT01396083Phase 3
46Ozurdex for Retinal Vein Occlusion Study (ORVO Study)CompletedNCT01790685Phase 2, Phase 3
47Effect of Ozurdex® 0.7 mg on Improvement of Efficacy of Bevacizumab for Central Retinal Vein OcclusionCompletedNCT01295112Phase 2, Phase 3
48Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI)CompletedNCT01512901Phase 2, Phase 3
49Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein OcclusionCompletedNCT01535261Phase 3
50Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein OcclusionCompletedNCT01599650Phase 3

Search NIH Clinical Center for Retinal Vascular Occlusion

Genetic Tests for Retinal Vascular Occlusion

About this section

Anatomical Context for Retinal Vascular Occlusion

About this section

MalaCards organs/tissues related to Retinal Vascular Occlusion:

33
Eye, Endothelial, Bone, Retina, Bone marrow, Thyroid, Skin

Animal Models for Retinal Vascular Occlusion or affiliated genes

About this section

MGI Mouse Phenotypes related to Retinal Vascular Occlusion:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053708.5F5, IL6, PLG, SELP, SERPINC1, VEGFA
2MP:00053918.3IL6, MTHFR, PLG, SELP, SERPINC1, VEGFA
3MP:00107718.1F2, F5, IL6, MTHFR, PLG, SELP
4MP:00053857.8F2, F5, IL6, PLG, SELP, SERPINC1
5MP:00036317.5F2, F5, IL6, MTHFR, PLG, SELP
6MP:00053897.4F2, FANCG, IL6, MTHFR, PLG, SERPINC1
7MP:00053767.0APOH, F2, F5, IL6, MTHFR, PLG
8MP:00107686.8APOH, F2, F5, IL6, MTHFR, PLG

Publications for Retinal Vascular Occlusion

About this section

Articles related to Retinal Vascular Occlusion:

(show top 50)    (show all 70)
idTitleAuthorsYear
1
Prevalence of meconium ileus marks the severity of mutations of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene. (26087176)
2015
2
Acoustically evoked auditory change complex in children with auditory neuropathy spectrum disorder: a potential objective tool for identifying cochlear implant candidates. (25422994)
2015
3
Cumulative effects of the ApoE genotype and gender on the synaptic proteome and oxidative stress in the mouse brain. (24810422)
2014
4
Optical coherence tomography: a quantitative tool to screen for papilledema in craniosynostosis. (24519451)
2014
5
Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity. (23929302)
2014
6
Transcriptionally-correlated sub-cellular dynamics of MBNL1 during lens development and their implication for the molecular pathology of Myotonic Dystrophy Type 1. (24354850)
2013
7
Genetic screens to identify pathogenic gene variants in the common cancer predisposition Lynch syndrome. (23690608)
2013
8
C/EBPI+ mediates the transcriptional suppression of human calreticulin gene expression by TNFI+. (22024156)
2012
9
Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence. (21645334)
2011
10
Embryonic ectoderm development protein is regulated by microRNAs in human neural tube defects. (21497788)
2011
11
Clinical use of Haemate-P in inherited von Willebrand's disease: a patient with type 3 VWD and recurrent menometrorrhagia. (20059558)
2010
12
Does gallbladder cancer divide India? (20373078)
2010
13
Biliary atresia. (20484362)
2010
14
Electron microscopic immunogold localization of statherin in human minor salivary glands. (20345857)
2010
15
High resolution melting analysis for JAK2 Exon 14 and Exon 12 mutations: a diagnostic tool for myeloproliferative neoplasms. (19225136)
2009
16
PTEN represses RNA polymerase III-dependent transcription by targeting the TFIIIB complex. (18391023)
2008
17
Multiplex real-time PCR detecting Salmonella, Shigella and diarrheagenic Escherichia coli]. (18399125)
2007
18
Accumulated mannitol and aggravated cerebral edema in a rat model of middle cerebral artery infarction. (19096566)
2007
19
Eosinophilia is associated with a higher mortality rate among patients with autoimmune lymphoproliferative syndrome. (17266055)
2007
20
Structure and kinetics of monofunctional proline dehydrogenase from Thermus thermophilus. (17344208)
2007
21
Interactions between epiplakin and intermediate filaments. (16923132)
2006
22
In situ photoactivation of a caged phosphotyrosine peptide derived from focal adhesion kinase temporarily halts lamellar extension of single migrating tumor cells. (15817454)
2005
23
A role for proapoptotic BID in the DNA-damage response. (16122425)
2005
24
Serum concentrations of macrophage inhibitory cytokine 1 (MIC 1) as a predictor of miscarriage. (14726168)
2004
25
Association of homozygosity for short allele (S) of heavy neurofilament subunit gene with motor neuron disease and oxidative stress development]. (12674703)
2003
26
Cell cycle regulatory protein expression in fresh acute myeloid leukemia cells and after drug exposure. (11368357)
2001
27
Genetic alterations in patients with primary aldosteronism. (11675938)
2001
28
A novel post-transcriptional splicing form of the acute T cell leukemia proto-oncogene Lmo2. (18763096)
2001
29
Correlation of p16 hypermethylation with p16 protein loss in sporadic gastric carcinomas. (10830779)
2000
30
Infratentorial and supratentorial leukoencephalopathy associated with vitamin B12 deficiency. (17895210)
2000
31
Molecular complex of cholecystokinin-8 and N-terminus of the cholecystokinin A receptor by NMR spectroscopy. (10555959)
1999
32
Tumor necrosis factor alpha regulation of the FAS-mediated apoptosis-signaling pathway in synovial cells. (10088775)
1999
33
The graded effect of hyperhomocysteinemia on the severity and extent of coronary atherosclerosis. (10559524)
1999
34
Hepatopulmonary syndrome associated with sarcoidosis of the liver: case report. (9879271)
1998
35
Direct luteinizing hormone action triggers adrenocortical tumorigenesis in castrated mice transgenic for the murine inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene. (9626655)
1998
36
Genomic imprinting and audiogenic seizures in mice. (9336083)
1997
37
Regulation of epidermal growth factor receptor synthesis by ovarian steroids in human endometrial cells in culture. (8882285)
1996
38
Pharmacologic modulation by cetirizine of some adhesion molecules expression in psoriatic skin lesions. (7591422)
1995
39
Twin studies in insulin dependent diabetes and other autoimmune diseases. (7555564)
1995
40
Cytoskeletal basis for contractility of outer hair cells in the normal adult human organ of Corti: comparisons with vestibular hair cells. (7731659)
1995
41
Epidermal growth factor enhances proliferation, migration, and invasion of follicular and papillary thyroid cancer in vitro and in vivo. (8045955)
1994
42
Progressive language disorder due to lobar atrophy. (1575456)
1992
43
Efficacy of ciclopiroxolamine 1% cream in onychomycosis and tinea pedis. (1833642)
1991
44
Eosinophilic cystitis in a renal allograft recipient. (2374203)
1990
45
Strict clinicopathologic criteria in the diagnosis of partial hydatidiform mole: a plea renewed. (3895965)
1985
46
Pycnodysostosis. (6526777)
1984
47
A breeding study to control chronic progressive nephrosis in rats. (7162129)
1982
48
Pseudohypoparathyroidism: inheritance of deficient receptor-cyclase coupling activity. (6265935)
1981
49
Female pseudohermaphroditism caused by maternal congenital adrenal hyperplasia. (469669)
1979
50

Variations for Retinal Vascular Occlusion

About this section

Expression for genes affiliated with Retinal Vascular Occlusion

About this section
Search GEO for disease gene expression data for Retinal Vascular Occlusion.

Pathways for genes affiliated with Retinal Vascular Occlusion

About this section

Pathways related to Retinal Vascular Occlusion according to GeneCards Suite gene sharing:

(show all 13)
idSuper pathwaysScoreTop Affiliating Genes
19.8SERPINC1, VEGFA
29.6CCL2, VEGFA
39.5F2, PLG
49.1IL6, PLG, SELP
59.0CCL2, IL6, VEGFA
69.0CCL2, IL6, VEGFA
79.0CCL2, IL6, SELP
89.0CCL2, IL6, SELP
9
Show member pathways
8.9F2, F5, PLG, SERPINC1
10
Show member pathways
8.9F2, F5, PLG, SERPINC1
11
Show member pathways
8.4CCL2, F2, IL6, PLG
12
Show member pathways
8.1CCL2, F2, IL6, MTHFR, PLG
13
Show member pathways
6.9APOH, CCL2, F2, F5, IL6, PLG

GO Terms for genes affiliated with Retinal Vascular Occlusion

About this section

Biological processes related to Retinal Vascular Occlusion according to GeneCards Suite gene sharing:

(show all 17)
idNameGO IDScoreTop Affiliating Genes
1regulation of blood coagulationGO:003019310.3APOH, F2
2positive regulation of collagen biosynthetic processGO:003296710.0CCL2, F2
3response to amino acidGO:004320010.0IL6, MTHFR
4response to antibioticGO:00466779.9CCL2, IL6
5defense response to Gram-negative bacteriumGO:00508299.8IL6, SELP
6platelet degranulationGO:00025769.7APOH, PLG, VEGFA
7positive regulation of leukocyte migrationGO:00026879.6CCL2, SELP, VEGFA
8positive regulation of cell adhesionGO:00457859.6CCL2, SELP, VEGFA
9cellular response to interleukin-1GO:00713479.6CCL2, IL6
10response to bacteriumGO:00096179.6CCL2, IL6
11platelet activationGO:00301689.6IL6, SELP, VEGFA
12cellular response to dexamethasone stimulusGO:00715499.3CCL2, IL6
13response to woundingGO:00096119.3CCL2, F2, IL6
14blood coagulationGO:00075969.1F2, F5, PLG, VEGFA
15response to heatGO:00094089.0CCL2, IL6
16regulation of cell shapeGO:00083608.7CCL2, F2, IL6, VEGFA
17cellular protein metabolic processGO:00442678.7CCL2, F2, F5, PLG

Sources for Retinal Vascular Occlusion

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet